Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study

• Hlavní autoři: Li H (Autor), Qin S (Autor), Liu Y (Autor), Chen Z (Autor), Ren Z (Autor), Xiong J (Autor), Meng Z (Autor), Zhang X (Autor), Wang L (Autor), Zou J (Autor)
• Médium: Kniha
• Vydáno: Dove Medical Press, 2021-05-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Hui Li,1,* Shukui Qin,1,* Ying Liu,2 Zhendong Chen,3 Zhenggang Ren,4 Jianping Xiong,5 Zhiqiang Meng,6 Xiao Zhang,7 Linna Wang,7 Xiaojing Zhang,7 Jianjun Zou7 1Department of Medical Oncology Center, Bayi Affiliated Hospital, Nanjing University of Chinese Medicine, Nanjing, People’s Republic...